RSS-Feed abonnieren
DOI: 10.1055/s-0031-1291377
Congenital Amegakaryocytic Thrombocytopenia: Clinical Presentation, Diagnosis, and Treatment
Publikationsverlauf
Publikationsdatum:
18. November 2011 (online)

ABSTRACT
Congenital amegakaryocytic thrombocytopenia (CAMT, MIM #604498) is a rare inherited bone marrow failure syndrome presenting as isolated hypomegakaryocytic thrombocytopenia at birth without other characteristic physical anomalies. Most of the patients develop a severe aplastic anemia and trilineage cytopenia during the first years of life and hematopoietic stem cell transplantation is the only curative treatment. In most of the cases the disease is caused by homozygous or compound heterozygous mutations in the gene MPL encoding the receptor for the hematopoietic growth factor thrombopoietin. The present review summarizes clinical and laboratory data for 96 patients with CAMT, reported since 1990.
KEYWORDS
Bone marrow failure - thrombopoietin - MPL gene - hematopoietic stem cell transplantation - thrombocytopenia
REFERENCES
- 1
Online Mendelian Inheritance in Man .
Amegakaryocytic thrombocytopenia, congenital; CAMT.
http://www.ncbi.nlm.nih.gov/omim/604498
(Feb 25, 2011)
MissingFormLabel
- 2
Ihara K, Ishii E, Eguchi M et al..
Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia.
Proc Natl Acad Sci U S A.
1999;
96
(6)
3132-3136
MissingFormLabel
- 3
Ballmaier M, Germeshausen M, Schulze H et al..
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Blood.
2001;
97
(1)
139-146
MissingFormLabel
- 4
Kaushansky K.
Thrombopoietin: the primary regulator of platelet production.
Blood.
1995;
86
(2)
419-431
MissingFormLabel
- 5
Ballmaier M, Germeshausen M.
Advances in the understanding of congenital amegakaryocytic thrombocytopenia.
Br J Haematol.
2009;
146
(1)
3-16
MissingFormLabel
- 6
Auerbach A D.
A test for Fanconi's anemia.
Blood.
1988;
72
(1)
366-367
MissingFormLabel
- 7
Freedman M H.
Congenital Marrow Failure Syndromes and Malignant Hematopoietic Transformation.
Oncologist.
1996;
1
(6)
354-360
MissingFormLabel
- 8
Guinan E C, Lee Y S, Lopez K D et al..
Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis
in congenital amegakaryocytic thrombocytopenia.
Blood.
1993;
81
(7)
1691-1698
MissingFormLabel
- 9
Muraoka K, Ishii E, Tsuji K et al..
Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone
marrow cells in congenital amegakaryocytic thrombocytopenia.
Br J Haematol.
1997;
96
(2)
287-292
MissingFormLabel
- 10
Henter J I, Winiarski J, Ljungman P, Ringdén O, Ost A.
Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia.
Bone Marrow Transplant.
1995;
15
(5)
799-801
MissingFormLabel
- 11
Muraoka K, Ishii E, Ihara K et al..
Successful bone marrow transplantation in a patient with c-mpl-mutated congenital
amegakaryocytic thrombocytopenia from a carrier donor.
Pediatr Transplant.
2005;
9
(1)
101-103
MissingFormLabel
- 12
MacMillan M L, Davies S M, Wagner J E, Ramsay N K.
Engraftment of unrelated donor stem cells in children with familial amegakaryocytic
thrombocytopenia.
Bone Marrow Transplant.
1998;
21
(7)
735-737
MissingFormLabel
- 13
Guinan E C, Boussiotis V A, Neuberg D et al..
Transplantation of anergic histoincompatible bone marrow allografts.
N Engl J Med.
1999;
340
(22)
1704-1714
MissingFormLabel
- 14
Lackner A, Basu O, Bierings M et al..
Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia.
Br J Haematol.
2000;
109
(4)
773-775
MissingFormLabel
- 15
van den Oudenrijn S, Bruin M, Folman C C et al..
Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic
thrombocytopenia.
Br J Haematol.
2000;
110
(2)
441-448
MissingFormLabel
- 16
van den Oudenrijn S, de Haas M, von dem Borne A E.
Screening for c-mpl mutations in patients with congenital amegakaryocytic thrombocytopenia
identifies a polymorphism.
Blood.
2001;
97
(11)
3675-3676
MissingFormLabel
- 17
van den Oudenrijn S, Bruin M, Folman C C, Bussel J, de Haas M, von dem Borne A E.
Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte
culture, distinguish between different causes of congenital thrombocytopenia.
Br J Haematol.
2002;
117
(2)
390-398
MissingFormLabel
- 18
King S, Germeshausen M, Strauss G, Welte K, Ballmaier M.
Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of
20 patients.
Br J Haematol.
2005;
131
(5)
636-644
MissingFormLabel
- 19
Germeshausen M, Ballmaier M, Welte K.
MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia:
the type of mutation predicts the course of the disease.
Hum Mutat.
2006;
27
(3)
296
MissingFormLabel
- 20
Yeşilipek H V, Hazar V, Küpesiz A, Yegin O.
Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.
Bone Marrow Transplant.
2000;
26
(5)
571-572
MissingFormLabel
- 21
Kudo K, Kato K, Matsuyama T, Kojima S.
Successful engraftment of unrelated donor stem cells in two children with congenital
amegakaryocytic thrombocytopenia.
J Pediatr Hematol Oncol.
2002;
24
(1)
79-80
MissingFormLabel
- 22
Al-Ahmari A, Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, El-Solh H.
Allogeneic stem cell transplantation for patients with congenital amegakaryocytic
thrombocytopenia (CAT).
Bone Marrow Transplant.
2004;
33
(8)
829-831
MissingFormLabel
- 23
Steele M, Hitzler J, Doyle J J et al..
Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen
barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy
7.
Pediatr Blood Cancer.
2005;
45
(2)
212-216
MissingFormLabel
- 24
Gandhi M J, Pendergrass T W, Cummings C C, Ihara K, Blau C A, Drachman J G.
Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis
of atypical clinical presentation.
Exp Hematol.
2005;
33
(10)
1215-1221
MissingFormLabel
- 25
Passos-Coelho J L, Sebastião M, Gameiro P et al..
Congenital amegakaryocytic thrombocytopenia—report of a new c-mpl gene missense mutation.
Am J Hematol.
2007;
82
(3)
240-241
MissingFormLabel
- 26
Pemberton L C, Levett D, Skinner R, Hall A G, Hanley J P.
Novel mutations in a child with congenital amegakaryocytic thrombocytopenia.
Br J Haematol.
2006;
135
(5)
742-743
MissingFormLabel
- 27
Savoia A, Dufour C, Locatelli F et al..
Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences
of five novel mutations.
Haematologica.
2007;
92
(9)
1186-1193
MissingFormLabel
- 28
Tonelli R, Scardovi A L, Pession A et al..
Compound heterozygosity for two different amino-acid substitution mutations in the
thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia
(CAMT).
Hum Genet.
2000;
107
(3)
225-233
MissingFormLabel
- 29
Maserati E, Panarello C, Morerio C et al..
Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic
thrombocytopenia (OMIM 604498).
Haematologica.
2008;
93
(8)
1271-1273
MissingFormLabel
- 30
Desai S R, Ranade S R.
Congenital amegakaryocytic thrombocytopenia (CAMT): a case report with review of literature.
Indian J Pathol Microbiol.
2007;
50
(3)
659-660
MissingFormLabel
- 31
Steinberg O, Gilad G, Dgany O et al..
Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic
correlations.
J Pediatr Hematol Oncol.
2007;
29
(12)
822-825
MissingFormLabel
- 32
Tamary H, Nishri D, Yacobovich J et al..
Frequency and natural history of inherited bone marrow failure syndromes: the Israeli
Inherited Bone Marrow Failure Registry.
Haematologica.
2010;
95
(8)
1300-1307
MissingFormLabel
- 33
Bastida Eizaguirre M, Pereda Vicandi A, Pujana Zaldegui I.
[Congenital amegakaryocytic thrombocytopenia in a 12 year old boy with no signs of
pancytopenia: molecular analysis].
An Pediatr (Barc).
2008;
68
(4)
353-356
MissingFormLabel
- 34
Kanaji S, Kanaji T, Migita M et al..
Characterization of a patient with atypical amegakaryocytic thrombocytopenia.
Eur J Haematol.
2008;
80
(4)
361-364
MissingFormLabel
- 35
Fox N E, Chen R, Hitchcock I, Keates-Baleeiro J, Frangoul H, Geddis A E.
Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia:
functional characterization and a review of the literature.
Exp Hematol.
2009;
37
(4)
495-503
MissingFormLabel
- 36
Rose M J, Nicol K K, Skeens M A, Gross T G, Kerlin B A.
Congenital amegakaryocytic thrombocytopenia: the diagnostic importance of combining
pathology with molecular genetics.
Pediatr Blood Cancer.
2008;
50
(6)
1263-1265
MissingFormLabel
- 37
Frangoul H, Keates-Baleeiro J, Calder C et al..
Unrelated bone marrow transplant for congenital amegakaryocytic thrombocytopenia:
report of two cases and review of the literature.
Pediatr Transplant.
2010;
14
(4)
E42-E45
MissingFormLabel
- 38
Chung H S, Koh K N, Kim H J et al..
A novel nonsense mutation in the MPL gene in congenital amegakaryocytic thrombocytopenia.
Pediatr Blood Cancer.
2011;
56
(2)
304-306
MissingFormLabel
- 39
Conde N, Quintero A E, Rives S et al..
Congenital amegakaryocytic thrombocytopenia (CAMT): a difficult early diagnosis.
Haematologica.
2010;
95
(Suppl 2)
412-413
MissingFormLabel
- 40
Martinón-Torres N, Vázquez-Donsión M, Loidi L, Couselo J M.
CAMT in a female with developmental delay, facial malformations and central nervous
system anomalies.
Pediatr Blood Cancer.
2011;
56
(3)
452-453
MissingFormLabel
- 41
Poles A, Keen L, Steward C et al..
Identification of mutations in the C-MPL gene confirms diagnosis of congenital amegakaryocytic
thrombocytopenia (CAMT).
[abstract]
Int J Immunogenet.
2010;
37
(5)
423
MissingFormLabel
- 42 Alter B P. Inherited bone marrow failure syndromes. In: Nathan D G, Stranahan R A, Orkin S H, Look A T, Ginsburg D, eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Philadelphia: Saunders W.B.; 2003: 280-365
MissingFormLabel
- 43
Dame C, Wolber E M, Freitag P, Hofmann D, Bartmann P, Fandrey J.
Thrombopoietin gene expression in the developing human central nervous system.
Brain Res Dev Brain Res.
2003;
143
(2)
217-223
MissingFormLabel
- 44
Ehrenreich H, Hasselblatt M, Knerlich F et al..
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain.
Proc Natl Acad Sci U S A.
2005;
102
(3)
862-867
MissingFormLabel
- 45
Ivanova A, Wuerfel J, Zhang J, Hoffmann O, Ballmaier M, Dame C.
Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous
system.
BMC Dev Biol.
2010;
10
77
MissingFormLabel
- 46
Hoffmann O, Rung O, Im A R et al..
Thrombopoietin contributes to neuronal damage in experimental bacterial meningitis.
Infect Immun.
2011;
79
(2)
928-936
MissingFormLabel
- 47
Khabbaze Y, Karayalcin G, Paley C, Shende A, Valderrama E, Lipton J M.
Thrombocytopenia absent corpus callosum syndrome: third case of a distinct clinical
entity.
J Pediatr Hematol Oncol.
2001;
23
(7)
469-471
MissingFormLabel
- 48
Knight S W, Heiss N S, Vulliamy T J et al..
Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson
syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.
Br J Haematol.
1999;
107
(2)
335-339
MissingFormLabel
- 49
Geddis A E.
Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii.
Hematol Oncol Clin North Am.
2009;
23
(2)
321-331
MissingFormLabel
- 50
Souyri M, Vigon I, Penciolelli J-F, Heard J M, Tambourin P, Wendling F.
A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia
virus immortalizes hematopoietic progenitors.
Cell.
1990;
63
(6)
1137-1147
MissingFormLabel
- 51
Beer P A, Ortmann C A, Stegelmann F et al..
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative
neoplasms.
Haematologica.
2010;
95
(12)
2153-2156
MissingFormLabel
- 52
Bagby G C, Meyers G.
Bone marrow failure as a risk factor for clonal evolution: prospects for leukemia
prevention.
Hematology (Am Soc Hematol Educ Program).
2007;
40-46
MissingFormLabel
- 53
Roberts I, Stanworth S, Murray N A.
Thrombocytopenia in the neonate.
Blood Rev.
2008;
22
(4)
173-186
MissingFormLabel
- 54
Giampietro P F, Verlander P C, Davis J G, Auerbach A D.
Diagnosis of Fanconi anemia in patients without congenital malformations: an international
Fanconi Anemia Registry Study.
Am J Med Genet.
1997;
68
(1)
58-61
MissingFormLabel
- 55
Basel-Vanagaite L, Dokal I, Tamary H et al..
Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused
by TERT mutations.
Haematologica.
2008;
93
(6)
943-944
MissingFormLabel
- 56
Mehta P, Locatelli F, Stary J, Smith F O.
Bone marrow transplantation for inherited bone marrow failure syndromes.
Pediatr Clin North Am.
2010;
57
(1)
147-170
MissingFormLabel
- 57
Shimamura A, Alter B P.
Pathophysiology and management of inherited bone marrow failure syndromes.
Blood Rev.
2010;
24
(3)
101-122
MissingFormLabel
- 58
Bizzetto R, Bonfim C, Rocha V Eurocord and SAA-WP from EBMT et al.
Outcomes after related and unrelated umbilical cord blood transplantation for hereditary
bone marrow failure syndromes other than Fanconi anemia.
Haematologica.
2011;
96
(1)
134-141
MissingFormLabel
- 59
Cocault L, Bouscary D, Le Bousse Kerdiles C et al..
Ectopic expression of murine TPO receptor (c-mpl) in mice is pathogenic and induces
erythroblastic proliferation.
Blood.
1996;
88
(5)
1656-1665
MissingFormLabel
- 60
Yan X Q, Lacey D L, Saris C et al..
Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis
but enhanced erythropoiesis in mice.
Exp Hematol.
1999;
27
(9)
1409-1417
MissingFormLabel
- 61
Wicke D C, Meyer J, Buesche G et al..
Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.
Mol Ther.
2010;
18
(2)
343-352
MissingFormLabel
- 62
Lannutti B J, Epp A, Roy J, Chen J, Josephson N C.
Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction
of the stem cell-repopulating defect and paradoxical thrombocytosis.
Blood.
2009;
113
(8)
1778-1785
MissingFormLabel
- 63
Heckl D, Wicke D C, Brugman M H et al..
Lentiviral gene transfer regenerates hematopoietic stem cells in a mouse model for
Mpl-deficient aplastic anemia.
Blood.
2011;
117
(14)
3737-3747
MissingFormLabel
Matthias BallmaierPh.D.
Pediatric Hematology and Oncology/Molecular Hematopoiesis, OE9411 - J11-H0-1110, Medizinische
Hochschule Hannover
Carl-Neuberg- Strasse 1, D-30625 Hannover, Germany
eMail: Ballmaier.Matthias@mh-hannover.de